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Abstract
Background: Survivors of acute kidney injury (AKI) are at risk of adverse outcomes. Post-discharge nephrology care may
improve patients’ AKI knowledge and prevent post-AKI complications.
Objective: The purpose of this study was to examine patients’ awareness about their AKI diagnosis and self-rated knowledge
and severity of AKI before and after their first post-discharge AKI Clinic encounter.
Design: We conducted a pre- and post-survey study among AKI survivors who attended a post-discharge AKI Clinic.
Setting: AKI Clinic at the University of Kentucky Medical Center (October 2016 to December 2017). Education about
AKI was based on transformative learning theory and provided through printed materials and interdisciplinary interactions
between patients/caregivers and nurses, pharmacists, and nephrologists.
Patients: A total of 104 patients completed the survey and were included in the analysis.
Measurements: Three survey questions were administered before and after the first AKI Clinic encounter: Question 1
(yes-no) for awareness, and questions 2 and 3 (Likert scale, 1 = lowest to 5 = highest) for self-rated knowledge and severity
of AKI.
Methods: Two mixed-model analysis of variance (ANOVA) was used for between-group (AKI severity) and within-group
(pre- and post-encounter) comparisons. Logistic regression was used to examine parameters associated with the withingroup change in self-perceived knowledge.
Results: Twenty-two out of 104 (21%) patients were not aware of their AKI diagnosis before the clinic encounter. Patients’
self-ratings of their AKI knowledge significantly increased after the first AKI Clinic encounter (mean ± SEM: pre-visit = 1.94
± 0.12 to post-visit = 3.88 ± 0.09, P = .001), even after adjustment for age, gender, Kidney Disease Improving Global Outcomes
(KDIGO) severity stage, or poverty level. Patients with AKI stage 3 self-rated their AKI as more severe than patients with
AKI stage 1 or 2.
Limitations: Our study population may not be representative of the general AKI survivor population. Administered surveys
are subject to response-shift bias.
Conclusions: Patients’ self-perceived knowledge about AKI significantly increased following the first post-discharge AKI
Clinic encounter that included interdisciplinary education. This is the first survey study examining self-perceived AKI
knowledge in AKI survivors. Further examination of AKI literacy in survivors of AKI and its effect on post-AKI outcomes is
needed.
Trial registration: Not applicable.
Abrégé
Contexte: Les survivants d’un épisode d’insuffisance rénale aiguë (IRA) risquent de souffrir de pathologies associées. Un
suivi en néphrologie après la sortie de l’hôpital pourrait accroître les connaissances des patients sur la maladie et prévenir
les complications.
Objectif: L’étude était bipartite : i) savoir si les patients connaissaient leur diagnostic; ii) mesurer, par auto-évaluation, les
connaissances des patients sur l’IRA et sur sa gravité, avant et après une consultation dans une clinique d’IRA.
Type d’étude: Un sondage mené auprès de survivants d’un épisode d’IRA, avant et après une consultation en clinique d’IRA
suivant leur congé de l’hôpital.
Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons AttributionNonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction
and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages
(https://us.sagepub.com/en-us/nam/open-access-at-sage).
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Cadre: La clinique d’IRA du centre médical de l’université du Kentucky (d’octobre 2016 à décembre 2017). L’information
fournie suivait la théorie de l’apprentissage transformationnel et était transmise sous forme de documents imprimés et
d’interactions interdisciplinaires entre les patients/fournisseurs de soins et les infirmières, les pharmaciens et les néphrologues.
Participants: L’étude porte sur 104 patients ayant complété le sondage.
Mesures: Trois questions ont été posées aux patients avant et après une première consultation à la clinique. Une question
portait sur leur connaissance du diagnostic (oui -non) et deux autres auto-évaluaient leurs connaissances sur l’IRA et sa
gravité (échelle de Likert, de 1 [plus faible] à 5 [plus élevé]).
Méthodologie: Deux modèles mixtes d’analyse de variance ont été employés pour établir des comparaisons inter-groupes
(gravité de l’IRA) et intra-groupes (pré et post-consultation). Une régression logistique a été utilisée pour analyser les
paramètres associés aux changements du niveau auto-évalué des connaissances dans un même groupe.
Résultats: Des 104 patients inclus à l’étude, 22 (21 %) ignoraient leur diagnostic d’IRA avant la consultation. L’auto-évaluation
des connaissances a augmenté après la première consultation (moyenne ± SEM : 1,94 ± 0,12 [pré-visite]; 3,88 ± 0,09 [postvisite], p=0,001) et ce, même après les ajustements en regard de l’âge et du sexe du patient, du stade de la maladie selon le
KDIGO (Kidney Disease Improving Global Outcomes) ou du niveau de revenus. Les patients atteints d’une IRA de stade 3 ont
davantage surévalué la gravité de leur maladie que les patients de stades 1 ou 2.
Limites: La population étudiée pourrait ne pas être représentative de la population générale des survivants d’un épisode
d’IRA. Les sondages sont sujets aux biais liés aux changements de réponses.
Conclusion: L’auto-évaluation des connaissances a augmenté significativement après une première consultation à la clinique
d’IRA lorsque celle-ci incluait de l’information interdisciplinaire. Il s’agit de la première étude portant sur l’auto-évaluation des
connaissances de survivants d’un épisode d’IRA. Il est nécessaire d’examiner davantage la littératie de l’IRA chez les survivants
de la maladie et ses effets sur les pathologies qui en découlent.
Keywords
Acute kidney injury, self-rated knowledge, patient education
Received September 4, 2018. Accepted for publication December 21, 2018.

What was known before

Introduction

To our knowledge, this is the first pre- and post-survey study
examining awareness and self-perceived acute kidney injury
(AKI) knowledge in survivors of AKI followed in a specialized AKI Clinic, in which interdisciplinary educational interventions were implemented.

Acute kidney injury (AKI) occurs in approximately 20% of
hospitalized patients, and the incidence doubles in patients
admitted to intensive care units.1,2 Acute kidney injury carries high morbidity and mortality and adversely influences
hospital resource utilization and health care costs,3,4 particularly in critically ill patients in whom mortality rates are as
high as 50%.4,5 Post-AKI complications are also common
and include the development or progression of chronic kidney disease (CKD),6-9 hypertension,10 and cardiovascular
disease.11-14 Acute kidney injury survivors are also susceptible to early rehospitalization and an overall increased risk of
long-term mortality.15,16

What this adds
The results of this study highlight patients’ AKI knowledge as a
potential modifiable intervention in survivors of AKI. Our study
may also have implications for what educational maneuvers
should physicians target when evaluating survivors of AKI.
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Figure 1. Patient selection for survey examination.

Note. AKI = acute kidney injury; RRT = renal replacement therapy.

Although AKI survivors are at high risk of several multiorgan complications, only a minority of them are evaluated
by a nephrologist within the first 3 months of hospital discharge.17-19 Furthermore, there are only few specialized AKI
Clinics dedicated to following AKI survivors post-discharge.20-22 In this context, there is paucity of research dedicated to examine and/or promote AKI literacy in AKI
survivors. Most importantly, there are no standardized or
validated educational tools or interventions to enhance AKI
knowledge in this susceptible population. Improving
patients’ knowledge about their AKI diagnosis is a cornerstone of post-AKI care and may be essential to promote kidney recovery and prevent recurrent episodes of AKI or the
development of CKD.
The purpose of this study was to examine patients’ awareness about their AKI diagnosis and patients’ self-rated AKI
knowledge before and after their participation in a specialized post-discharge AKI Clinic that has developed and
implemented educational tools to promote AKI knowledge
throughout the encounter experience. We hypothesized that
most of the patients who attend the AKI Clinic are aware of
their AKI diagnosis and that the overall experience during
the AKI Clinic visit will significantly improve their self-perceived knowledge about AKI, particularly in those who suffered from severe AKI.

Methods
Study Design
We conducted a survey study to examine AKI awareness and
self-rated AKI knowledge in AKI survivors followed in a
specialized post-discharge AKI Clinic. The same survey
questions were completed before and after the first AKI
Clinic visit. A total of 113 patients were evaluated in the
post-discharge AKI Clinic from October 2016 to December
2017 at the University of Kentucky Medical Center. Of these,
104 (92%) completed the survey examination and were
included in the study (Figure 1). The study was approved by
the institutional review board (IRB) of the University of
Kentucky (IRB: 17-0471-P2H).

AKI Clinic: Description
Acute kidney injury survivors were defined as patients who
have achieved clinical stability and were discharged from the
hospital, irrespective of their degree of kidney recovery.18 The
post-discharge AKI Clinic was established at the University of
Kentucky Medical Center in October of 2016 following the
model described by Silver and colleagues.22 The main goal of
the AKI Clinic was to evaluate kidney recovery in AKI survivors during the first 90 days post-discharge as this may be
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The first AKI Clinic visit was targeted to occur 4 to 6 weeks
after hospital discharge. Subsequent visits were scheduled at
3, 6, 12, and 18 months as outlined in the Supplementary
Figure 1. After the fifth visit, the nephrologist evaluated the
patient’s kidney function status and determined whether the
patient required referral to the CKD Clinic or if routine follow-up with his or her primary care provider would suffice.

AKI Clinic: Education Procedures

Figure 2. Interdisciplinary educational procedures performed in
the Acute Kidney Injury Clinic.

informative for their subsequent risk of recurrent AKI or incident/progressive CKD or end-stage renal disease (ESRD).23,24
The post-discharge AKI Clinic comprises an interdisciplinary
team of nurses, pharmacists, physician assistants, nephrologists
and ancillary staff, and has standard operating procedures that
include structured follow-up (Supplementary Figure 1) and
AKI education for patients and caregivers (Figure 2).

AKI Clinic: Target Patient Population
We use the following referral criteria for follow-up in the
AKI Clinic:
•• Inclusion criteria:
○ All patients diagnosed with severe AKI (Kidney
Disease Improving Global Outcomes [KDIGO]
stage 2 or 3)25 during a recent hospitalization.
Occasionally, patients with AKI stage 1 were
evaluated in the AKI Clinic at the request of the
inpatient nephrology consulting team
•• Exclusion criteria:
○ Baseline estimated glomerular filtration rate
(eGFR) <15 mL/min/1.73 m2
○ Kidney transplant recipients
○ Persistent requirement for outpatient hemodialysis at the time of hospital discharge

AKI Clinic: Referral Process and Structured
Follow-up Visits
Our AKI Clinic staff received referrals mostly coming from
inpatient nephrology consult teams at the time of signing off.

The education procedures were conducted during the entire
clinical encounter and were based on transformative learning
theory26 (critical reflection to challenge the learner’s beliefs
and assumptions). The first educational interaction (nursepatient, 10-15 minutes) occurred at the time of room boarding: (1) The nurse asked the patient about his or her
understanding of AKI using terms such as “acute kidney
injury,” “acute kidney failure,” “kidney damage,” “kidney
disease,” “sick kidneys,” and so on and through open questions and self-reflection of their recent hospital experience
(dissonance phase: recognize what is unknown); (2) the
nurse provided an educational handout containing information about AKI for the patient to review. The handout material is accessible through the National Kidney Foundation
website (Supplementary Figure 2)27 and includes information about the following: What is AKI? What are the most
common causes of AKI? What are the consequences of AKI?
What should you do to protect your kidneys after an episode
of AKI? The second educational interaction (pharmacistpatient, 10-15 minutes; organization phase) consisted of (1)
review of patients’ medication list; (2) review of use of overthe-counter supplements, pain control medications, or herbal
remedies; and (3) education regarding common nephrotoxic
drugs (ie, nonsteroidal anti-inflammatory agents) and the
importance to avoid these medications in the recovery phase
of AKI. The final and third educational interaction (physician or physician assistance-patient, 20-25 minutes) included
a comprehensive review of AKI etiology and characteristics,
patient- and hospitalization-specific risk factors, and the
identification of modifiable risk factors that can potentially
prevent new episodes of AKI and/or complications from
AKI. During this final interaction (feedback and consolidation phases), all patients’ and/or caregivers’ questions related
to preventive maneuvers and treatment plan were addressed
and answered. A summary of our educational interventions is
provided in Table 1.

AKI Clinic: Survey Examination
The survey was part of the standard-of-care operations of the
AKI Clinic and was administered by the ancillary staff before
and after the first clinic encounter. The person in charge of
administering the survey was not directly involved in the
educational procedures to minimize response-shift bias. The
survey consisted of 3 questions to determine awareness
about the AKI diagnosis, to determine self-rated knowledge
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Table 1. Educational Intervention About AKI Focusing on Three Main Domains.
Domain

Intervention

1. Education on understanding AKI
and its consequences

••
••
••
••

2. Education on modifiable risk
factors

••
••
••
••
••
••

3. E ducation on patient-specific risk
factors

••
••
••
••

Discussion about the main functions of the kidney for solute and fluid homeostasis
Discussion about the potential causes of AKI during the hospitalization
Discussion about the potential kidney-related complications after AKI
Discussion about the potential non-kidney-related complications after AKI (ie,
cardiovascular health)
Adequate hydration, particularly when exposed to heat
Blood pressure control with a goal of ≤140 mm Hg systolic and ≤90 mm Hg diastolic
(target is adjusted based on specific conditions)40
Glycemic control with a goal of hemoglobin A1C of <7%41
Avoidance of over-the-counter nephrotoxins (ie, nonsteroidal anti-inflammatory agents,
proton pump inhibitors, herbal remedies, etc.)25
Avoidance of unnecessary procedures that require intravascular administration of
iodinated contrast25
Lifestyle modifications25
BMI goal of 20-25 kg/m2
Exercise for at least 30 min 5 times per week
Limit alcohol and tobacco use
Lower salt intake to ~2 g (90 mmol) per day
Education on patient-specific risk factors such as underlying CKD, active cancer,
cardiovascular disease, advanced liver disease, etc.
Education on specific dietary restrictions
Education on the importance of individualized dosing of certain prescribed medications
according to current kidney functional status
Education about the importance of primary and/or subspecialty care for the
management of comorbidity

Note. AKI = acute kidney injury; BMI = body mass index; CKD = chronic kidney disease.

about AKI, and to determine self-rated severity of AKI. If the
patient answered “NO” to the first (awareness) question, we
assigned the lowest score to the following 2 questions for the
pre-encounter time point. The ancillary staff was trained to
use alternative terms to “acute kidney injury” such as “acute
kidney failure,” “kidney damage,” “kidney disease,” “sick
kidneys,” and so on when appropriate during the administration of the survey.
Question 1: Are you aware that you suffered from AKI
during your recent hospitalization? (yes-no)
Question 2: If you answered yes to the above question,
how would you rank the severity of your AKI? (Likert
scale ranging from 1 = lowest to 5 = highest according to
self-rated kidney function during the episode of AKI:
≤20%, 21%-40%, 41%-60%, 61%-80%, >80%)
Question 3: How would you rank your knowledge about
AKI? (Likert scale ranging from 1 = lowest to 5 = highest according to self-rated knowledge about AKI: very
poor, poor, fair, good, excellent)

Clinical Data and Definitions
We collected demographic, comorbidity, and social history
data from chart review. Poverty level was defined as the percentage of people whose income in the past 12 months is below
the poverty level of their area of residence. We determined

poverty level according to the postal code of residence for each
patient. We used poverty level as a surrogate metric of patients’
educational level. Baseline serum creatinine (SCr) was defined
as the outpatient SCr value closest to the day of hospital admission during the 6 months before the date of hospitalization.25 If
unavailable, the lowest SCr throughout the AKI hospitalization
was recorded as the baseline SCr. The duration of AKI was
defined as the period from AKI diagnosis to the improvement
(decrease) in SCr of at least 50% from the peak value. The AKI
recovery was determined if there was less than 25% eGFR
reduction from baseline at the time of first AKI Clinic encounter.28 We used Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI)29 equation for calculating eGFR. We
defined improvement of self-rated knowledge of AKI as an
increase of ≥1 versus <1 points from pre- to post-clinic
encounter in the applied survey scale. This variable was then
examined as a binary outcome.

Statistical Analysis
Data are reported as mean (SD) or median (IQR) for continuous variables or frequency and percentage for categorical
variables. The AKI KDIGO SCr-criteria 25 were used to create groups based on AKI severity. One-way analysis of variance (ANOVA) was used to compare continuous variables
across AKI severity groups. Chi-square analyses were conducted to compare categorical variables across groups. Two
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mixed-model ANOVAs were used to analyze patients’ selfrated knowledge about AKI and self-rated severity of their
AKI. We used post hoc comparison with Bonferroni correction to analyze the mean self-rated knowledge and severity
of AKI. The independent variables in both mixed-model
ANOVAs were AKI stage groups (ie, stages 1 and 2, stage 3,
and stage 3-RRT [renal replacement therapy]; between-subjects factor) or AKI recovery groups (YES/NO; betweensubjects factor) and time point (pre- and post-AKI Clinic
encounter; within-subjects factor). Patients’ self-rated
knowledge and severity was the dependent variable for the
mixed-model ANOVAs. Planned post hoc comparisons following significant main or interaction effects were conducted
with Sidak correction for both mixed-model ANOVAs.
Effect sizes for significant results were calculated as partial
eta squared ( η2p ). Observed power for significant results is
reported.
Finally, multivariable logistic regression models for
awareness of AKI diagnosis and improvement in self-rated
knowledge of AKI (from pre- to post-AKI Clinic encounter)
as dependent variables were constructed. The AKI severity
(stage 3 or 3-RRT vs stage 1 or 2) and AKI recovery status
were the main independent variables. Covariates forced into
the models were age, gender, Charlson comorbidity score,30
and poverty level. These covariates were selected based on
clinical rationale or univariate analysis. The model was
tested by the Hosmer and Lemeshow goodness-of-fit test.
Statistical analyses were performed in SPSS Version 22
(IBM Corporation, Armonk, New York) and SAS 9.4 (SAS
Institute, Cary, North Carolina) with an alpha level set at P ≤
.05 (2-tailed) for all comparisons.

out of 10 (60%) patients with AKI stage 1, 3 out of 9 (33.3%)
patients with AKI stage 2, 10 out of 50 (20%) patients with
AKI stage 3, and 3 out of 35 (8.5%) patients with AKI stage
3-RRT. Patients with AKI stage 3 or 3-RRT were more aware
of their AKI diagnosis than those with AKI stage 1 or 2, even
after adjustment for age, gender, Charlson score, and poverty
level (adjusted odds ratio [OR] = 3.74, 95% confidence
interval [CI] = 1.07-13.12, P = .038) (Table 3). Fifty-five
patients (52.9%) recovered at least 75% of kidney function
relative to baseline by the time of their first visit to the postdischarge AKI Clinic. The pre-visit awareness of AKI was
not associated with AKI recovery status (P = .93) (Table 3).
After the first AKI Clinic encounter, all patients were aware
of their recent AKI diagnosis.

Results

Patients who had AKI stage 3-RRT self-rated their AKI as
more severe than patients with AKI stage 3 or stages 1 and 2.
Similarly, patients with AKI stage 3 self-rated their AKI as
more severe than patients with AKI stages 1 and 2—main
effect of AKI severity stage, F(2, 91) = 12.62, P = .001, η2p
= 0.22, observed power =0.99 (Figure 4). There was no significant main effect of time point, F(1, 91) = 1.09, P = .30,
or time point by AKI severity group interaction, F(2, 91) =
2.02, P = .14. Exploratory correlations with Spearman rho
were conducted with peak SCr (during the hospitalization)
and the self-ratings of severity both pre- and post-AKI Clinic
encounters. Peak SCr was significantly and positively correlated with self-rated severity of AKI pre- and post-AKI
Clinic encounter: r = 0.31 (P = .001) and r = 0.43 (P =
.001), respectively.

Patients’ Characteristics
A total of 113 patients were followed in the AKI Clinic from
October 2016 through December 2017. Of these, 104 patients
completed the survey and were included in the analysis
(Figure 1). The mean (SD) patient age was 55.1 (13.8) years,
50% were male, and 88.5% were white. The median (IQR)
length of hospitalization was 13 (7-20) days. The median
(IQR) time between hospital discharge and the first AKI
Clinic encounter was 28 (13-45) days. Our cohort consisted
of 9 (8.7%) patients with AKI stage 1, 10 (9.6%) with AKI
stage 2, 50 (48.1%) with AKI stage 3, and 35 (33.6%) with
AKI stage 3-RRT. A total of 88 (84.6%) of patients had inpatient nephrology consultation for AKI management. Patients’
characteristics according to AKI severity stages are reported
in Table 2.

Patients’ Awareness About AKI Diagnosis
At the beginning of the first AKI Clinic encounter, 22
(21.2%) patients were not aware of their AKI diagnosis: 6

Patients’ Self-Rated Knowledge About AKI
Patients significantly improved their self-rated knowledge
about AKI following the first AKI Clinic encounter as there
was a significant main effect of time point, F(1, 91) =
160.94, P = .001, η2p = 0.64, observed power = 1.00.
However, there was no significant main effect of AKI severity group, F(2, 91) = 0.22, P = .81, or time point by AKI
severity group interaction, F(2, 91) = 1.14, P = .32 (Figure
3). The improvement in self-rated AKI knowledge from preto post-AKI Clinic encounter (mean ± SEM: pre-visit =
1.94 ± 0.12 to post-visit = 3.88 ± 0.09, P = .001) was not
associated with either AKI severity or AKI recovery status
(Table 3).

Patients’ Self-Rated Severity of Their AKI

Discussion
The principal finding of this study is that the implementation
of AKI education throughout the first visit encounter in a
specialized post-discharge AKI Clinic increased patients’
self-rated knowledge about AKI. Patients with more severe
AKI were more likely to be aware of their AKI diagnosis
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Table 2. Patient Characteristics.
All patients
(n = 104)
Demographics
Age, years, mean (SD)
Male, n (%)
White, n (%)
Poverty level (%), mean (SD)
Comorbidity
Charlson score, median (IQR
25th-75th)
Diabetes mellitus, n (%)
Hypertension, n (%)
Social history
Alcohol use, n (%)
Tobacco use, n (%)
Recreational drugs, n (%)
AKI characteristics
Baseline eGFR, mL/min/1.73
m2, mean (SD)
Baseline SCr, µmol/L, median
(IQR 25th-75th)
Peak SCr, µmol/L, median
(IQR 25th-75th)
AKI etiology
Pre-renal, n (%)
ATN, n (%)
Sepsis, n (%)
Other, n (%)
Duration of AKI, days, median
(IQR 25th-75th)
Total days on RRT, days,
median (IQR 25th-75th)
First clinic visit SCr, µmol/L,
median (IQR 25th-75th)
Discharge to first visit interval,
days, median (IQR 25th-75th)

55.1 (13.8)
52 (50.0)
92 (88.4)
20.76 (10.3)
3 (1.0-4.0)

AKI stages 1-2
(n = 19)
60.9 (8.9)
11 (57.9)
18 (94.7)
15.8 (9.2)
4 (3.0-7.0)

AKI stage 3
(n = 50)
53.5 (14.1)
24 (48.0)
43 (86.0)
22.1 (10.8)
2 (1.0-3.0)

AKI stage 3-RRT
(n = 35)
54.1 (13.8)
17 (48.6)
31 (88.6)
21.4 (9.8)
2 (1.0-4.0)

P
.14
.74
.76
.06
.005

49 (47.1)
71 (68.3)

10 (52.6)
12 (63.2)

21 (42.0)
36 (72.0)

18 (51.4)
23 (65.7)

.60
.72

43 (41.3)
60 (57.7)
16 (15.4)

9 (47.4)
8 (42.1)
2 (10.5)

19 (38.0)
31 (62.0)
10 (20.0)

15 (42.9)
21 (60.0)
4 (11.4)

.76
.30
.45

73.48 (31.7)

56.2 (16.7)

81.7 (35.1)

71.1 (29.3)

.009

88.42 (70.7-123.8)

109.64 (97.3-133.1)

70.74 (63.4-114.1)

88.42 (79.1-128.2)

.68

416.46 (287.4-563.0)

229.89 (176.4-251.6)

429.28 (319.9-523.4)

520.79 (382.9-676.4)

.001

4 (8.0)
24 (48.0)
17 (34.0)
5 (10.0)
12 (8.0-19.5)

3 (8.5)
14 (40.0)
18 (51.4)
—
17.5 (10.7-28.3)

—

—

5 (1.5-8.5)

130.86 (101.2-176.8)

137.94 (96.6-217.5)

.82
16 (15.3)
45 (43.2)
37 (35.6)
6 (5.7)
13 (7.5-25.0)

9 (47.4)
7 (36.8)
2 (10.5)
1 (5.2)
9 (4.5-12.5)

5 (1.5-8.5)
130.87 (93.7-189.7)
28 (12.7-45.0)

32 (12.0-51.0)

20 (12.0-35.0)

118.48 (88.4-166.2)
36 (19.5-47.5)

.05

.07
.18

Note. AKI = acute kidney injury; RRT = renal replacement therapy; IQR = interquartile range; eGFR = estimated glomerular filtration rate; SCr =
serum creatinine; ATN = acute tubular necrosis.

before the first clinic encounter with the nephrologist.
Importantly, almost one quarter of the patients did not know
that they suffered from AKI. These findings are timely and
critically important to aid the development of effective strategies to promote patients’ AKI knowledge, which may have
a positive impact on the prevention or amelioration of postAKI complications. We based our educational intervention
on 3 main domains. The first one focused on patient’s understanding about AKI and its consequences. The second one
consisted of the identification of modifiable risk factors,
such as blood pressure and glycemic control, healthy lifestyle changes (ie, weight loss, tobacco cessation), and avoidance of over-the-counter nephrotoxins (ie, nonsteroidal
anti-inflammatory agents). The third one focused on individualized preventive measurements according to specific

patient’s needs such as underlying CKD and another comorbidity that can affect kidney health (ie, active cancer, chemotherapy, cardiovascular disease, advanced liver disease, etc.).
This study constitutes the first step toward establishing and
validating educational tools and strategies to improve knowledge about AKI in survivors of AKI.
AKI survivors are at significant risk for renal and cardiovascular complications, and frequent rehospitalizations.11-16
Despite this evolving evidence, only a few AKI survivors follow up with a nephrologist or primary care physician in the
first few weeks after hospital discharge.31 According to the
2013 report from the US Renal Data System, 13% of AKI
survivors saw a nephrologist within 3 months of hospital discharge.32 Siew et al17 found that only 8.5% of AKI survivors
received a referral to a see a nephrologist. Similarly, Harel
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Table 3. Multivariable Logistic Regression Models of Pre-Encounter Awareness of AKI Diagnosis and Improvement in Self-Rated
Knowledge After the First AKI Clinic Encounter (Dependent Variables) and (a) AKI Severity (Stage 3 or 3-RRT vs Stage 1 or 2) and (b)
AKI Recovery Status (No Recovery vs Recovery) as the Main Independent Variables.
Awareness pre-encounter

AKI severity
AKI stage 3 or 3-RRTa
Age
Gender
Charlson score
Poverty metric
AKI recovery
No recoveryb
Age
Gender
Charlson score
Poverty metric

Self-rated knowledge improvement

OR

95% CI

P

OR

95% CI

P

3.74
0.82
0.78
1.12
1.12

1.1-13.1
0.6-1.0
0.3-2.2
0.7-1.7
0.9-1.2

.03
.09
.64
.59
.07

1.39
1.12
0.91
1.01
1.03

0.3-5.7
0.9-1.3
0.3-2.5
0.6-1.5
0.9-1.1

.64
.19
.85
.93
.54

1.04
0.82
0.78
0.97
1.15

0.3-3.1
0.7-1.1
0.3-2.2
0.6-1.5
1.01-1.3

.93
.06
.65
.86
.02

1.01
1.12
0.90
0.98
1.03

0.4-2.8
0.9-1.3
0.3-2.5
0.6-1.4
0.9-1.2

.97
.21
.84
.93
.49

Note. AKI = acute kidney injury; RRT = renal replacement therapy; OR = odds ratio; CI = confidence interval; eGFR = estimated glomerular filtration
rate.
a
In reference to AKI stage 1 or 2.
b
In reference to AKI recovery, determined if there was less than 25% eGFR reduction from baseline at the time of first AKI Clinic encounter.

Figure 3. Patients’ ratings of their self-rated knowledge before
and after the first AKI Clinic encounter (mixed-model ANOVA,
P = .001).

Figure 4. Patients’ ratings of their self-rated severity before and
after the first AKI Clinic encounter (mixed-model ANOVA, P =
.001).

Note. AKI = acute kidney injury; ANOVA = analysis of variance; KDIGO
= Kidney Disease Improving Global Outcomes.

Note. AKI = acute kidney injury; ANOVA = analysis of variance; KDIGO
= Kidney Disease Improving Global Outcomes.

et al19 studied a cohort of 3877 hospitalized patients with AKI
requiring RRT from 1996 to 2008 and found that only 40.8%
visited a nephrologist within 90 days of hospital discharge.
Patients who were referred to see a nephrologist (mean of 13

days from discharge to clinic visit) had a higher likelihood of
having preexisting CKD, hypertension, and a nephrologist’s
visit before the index hospitalization. Importantly, these
patients had a lower rate of death compared with those
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without nephrology follow-up (8.4 vs 10.6 per 100-patients
years, adjusted hazard ratio = 0.76, 95% CI = 0.62-0.93).
There are no well-established risk-stratification tools to
identify AKI survivors who can benefit from specialized
nephrology follow-up versus standard of care.7,33 These tools
need to integrate more accurate assessment of kidney function and kidney functional reserve utilizing novel biomarkers, functional imaging studies, and possibly machine
learning algorithms that provide information from available
clinical data.34-36 Before these tools are fully developed and
validated, it is reasonable to follow AKI survivors who suffered from severe AKI (KDIGO stage ≥2) or are suspected
to be at high risk for recurrent AKI or progression to CKD.31
The impact of specialized nephrology care in these patients
may be critical to prevent or ameliorate post-AKI adverse
outcome. However, the value of the AKI Clinic model needs
to be further studied with properly designed interventional
studies that focus not only on hard outcomes such as mortality, CKD, or ESRD but also on patient-centered outcomes
including quality of life, cardiovascular comorbidity and
cognitive function.18 We believe that the barriers for optimal
follow-up of AKI survivors include incomplete awareness of
the multiple AKI consequences by the health care team and
ineffective education maneuvers for patients and/or caregivers during the hospitalization.
Evolving evidence suggests that health literacy is essential in the care of patients with kidney disease. However,
most of these studies have focused on CKD patients. Taylor
et al37 performed a systematic review to explore the association between health literacy and clinical outcomes in patients
with CKD. They found that there is an association between
inadequate CKD literacy and hospitalizations and cardiovascular events in nondialysis CKD patients, and with reduced
dialysis adherence, hospitalizations, and mortality in dialysis
patients. Importantly, health literacy examination tools were
heterogeneous across studies limiting the reproducibility of
the findings. Similarly, Devraj et al38 described an association between health literacy and kidney function decline in
CKD patients. They used the Newest Vital Sign (NVS)
instrument to measure health literacy in a cohort of 150
patients with CKD stages 1 to 4 referred to an outpatient
nephrology clinic.39 They found that for every unit increase
in the health literacy metric, there was a 2.2% increase in the
eGFR during a follow-up of 5 months. The relationship
between health literacy and improvement in eGFR remained
significant after adjusting for gender and race but not after
adjusting for age. This evolving evidence supports our
hypothesis that improving the understanding of AKI and its
consequences in survivors of AKI may have a positive effect
on post-AKI outcomes. However, one should be cautious
when extrapolating health literacy data from CKD patients
into survivors of AKI with heterogeneous kidney recovery
phenotypes, particularly because it is not known which highrisk subgroups of AKI survivors may benefit the most from
dedicated educational interventions.

Our study has several strengths. First, this is the first survey study examining awareness and self-perceived AKI
knowledge in survivors from AKI followed in a specialized
AKI Clinic with standard educational interventions and
structured follow-up.22 Second, we utilized a survey that has
external and constructs validity as patients with more severe
forms of AKI had higher self-rated severity scores. Third,
our study suggests that simple and replicable interdisciplinary educational interventions may improve self-rated
patients’ knowledge about a complex syndrome such as AKI.
Our study also has limitations. First, administered surveys
are subject to response-shift bias. However, we minimize this
bias by not including the staff administering the survey in the
educational procedures. Second, the survey employed for this
study does not test the patient’s actual knowledge about AKI
but rather self-rated knowledge about this condition. However,
we consider that these data are critically informative to develop
and validate educational tools for AKI survivors. Third, our
study population may not be representative of the general AKI
survivor population, as we had prespecified criteria for clinic
referral and approximately 30% of all patients referred to the
clinic did not attend the clinic.

Conclusion
Almost one quarter of the patients were not aware of the
AKI diagnosis even after scheduling an appointment to follow in the post-discharge AKI Clinic. Patients’ self-rated
knowledge about AKI significantly increased following the
first AKI Clinic encounter in a specialized setting that
incorporated simple and replicable educational maneuvers
by an interdisciplinary team. Future studies should aim to
validate standard educational interventions in AKI survivors and, most importantly, examine the relationship
between AKI literacy and post-AKI outcomes in this susceptible population.
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